President Liz Thompson is leaving the Susan G. Komen for the Cure charitable foundation next month, along with founder Nancy Brinker, who is relinquishing her role as chief executive. Two board members are expected to follow suit.
The departures come on the heels of Komen's brief but controversial decision to end funding for Planned Parenthood earlier this year.
In February, Karen Handel, Komen's vice president for public policy, resigned from her post following the controversy. The Washington Post reports that several former Komen employees said Handel was shown the door following the decision to stop funding Planned Parenthood.
In an interview with the Wall Street Journal, Thompson said she is leaving her position, which she started in 2010, with a "heavy heart."
But Brinker seemed less apathetic regarding her departure, telling the Journal that Wednesday's changes had nothing to do with the controversy.
"I apologized to everyone. I think we all made mistakes and we addressed them and we're through that and we're moving on," she said.
Beyond Thompson and Brinker, the Washington Post reports that two Komen board members, Brenda Lauderback and Linda Law, announced they would leave the organization as well.
In a statement, Thompson added that Komen was “on an excellent path to recovery." She added that, "no other breast cancer organization does as much to help women and men through this disease.”